alendronate has been researched along with organophosphonates in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Barbier, A; Baslé, MF; Chappard, D; Filmon, R | 1 |
Balas, F; Horcajada, P; Manzano, M; Vallet-Regí, M | 1 |
Prutthiwanasan, B; Suntornsuk, L | 1 |
Lane, JM; Rebolledo, BJ; Unnanuntana, A | 1 |
Černič, T; Gyergyek, S; Horák, D; Kostiv, U; Lisjak, D; Majaron, B; Ponikvar-Svet, M; Vozlič, M | 1 |
5 other study(ies) available for alendronate and organophosphonates
Article | Year |
---|---|
Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: a composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process.
Topics: Alendronate; Alkaline Phosphatase; Biocompatible Materials; Bone and Bones; Calcium; Cartilage; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Fetus; Glycerophosphates; Humans; Microscopy, Electron; Microscopy, Electron, Scanning; Models, Chemical; Organophosphonates; Polyhydroxyethyl Methacrylate; Tibia; Time Factors; Zinc | 2000 |
Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials.
Topics: Adsorption; Alendronate; Bone Density Conservation Agents; Drug Carriers; Organophosphonates; Porosity; Silicon Dioxide; Surface Properties | 2006 |
Rapid analysis of alkylphosphonate drugs by capillary zone electrophoresis using indirect ultraviolet detection.
Topics: Alendronate; Benzoic Acid; Buffers; Clodronic Acid; Diphosphonates; Electrophoresis, Capillary; Fosfomycin; Hydrogen-Ion Concentration; Organophosphonates; Pharmaceutical Preparations; Phosphoric Acids; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet; Temperature | 2010 |
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidity; Fanconi Syndrome; Female; Femoral Neck Fractures; Fractures, Spontaneous; Hip Fractures; HIV Infections; Humans; Magnetic Resonance Imaging; Middle Aged; Organophosphonates; Osteoporotic Fractures; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure | 2011 |
Formation of phosphonate coatings for improved chemical stability of upconverting nanoparticles under physiological conditions.
Topics: Alendronate; Fluorescence; Fluorides; Hydrogen-Ion Concentration; Nanoparticles; Organophosphonates; Solubility; Surface Properties; Temperature; Ultrasonic Waves; Yttrium | 2021 |